LY-4268989
N/A
Report date: 2026/05/16 20:00:17
NME
Base Information
Drug NameLY-4268989
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[41]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMorphic Therapeutic Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesMorphic Therapeutic IncEli Lilly And CompanyPatheon Inc +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A